AnaptysBio
(NASDAQ) ANAB
AnaptysBio Financials at a Glance
Market Cap
$1.90B
Revenue (TTM)
$234.60M
Net Income (TTM)
$13.23M
EPS (TTM)
$-0.52
P/E Ratio
-127.01
Dividend
$0.00
Beta (Volatility)
0.88 (Low)
Dividend
$0.00
Beta (Volatility)
0.88 (Low)
Price
$66.70
Volume
181
Open
$67.16
Price
$66.70
Volume
181
Open
$67.16
Previous Close
$66.11
Daily Range
$65.06 - $71.67
52-Week Range
$11.40 - $71.67
Dividend
$0.00
Beta (Volatility)
0.88 (Low)
Price
$66.70
Volume
181
Open
$67.16
Previous Close
$66.11
Daily Range
$65.06 - $71.67
52-Week Range
$11.40 - $71.67
ANAB News
Why AnaptysBio Plummeted Today
ANAB: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout AnaptysBio
Industry
Biotechnology
Sector
Health CareEmployees
104
CEO
Daniel R. Faga, MBA
Website
www.anaptysbio.comHeadquarters
San Diego, CA 92121-5801, US
ANAB Financials
Key Financial Metrics (TTM)
Gross Margin
99%
Operating Margin
20%
Net Income Margin
-6%
Return on Equity
-24%
Return on Capital
15%
Return on Assets
-4%
Earnings Yield
-0.79%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.90B
Shares Outstanding
28.75M
Volume
181
Avg. Volume
603.65K
Financials (TTM)
Gross Profit
$232.18M
Operating Income
$47.90M
EBITDA
$50.32M
Operating Cash Flow
$19.70M
Capital Expenditure
$87.00K
Free Cash Flow
$19.61M
Cash & ST Invst.
$311.64M
Total Debt
$14.11M
AnaptysBio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$108.25M
+151.1%
Gross Profit
$216.24M
+41166.6%
Gross Margin
2.00%
N/A
Market Cap
$1.90B
N/A
Market Cap/Employee
$13.97M
N/A
Employees
136
N/A
Net Income
$49.61M
+327.8%
EBITDA
$67.51M
+1873.7%
Quarterly Fundamentals
Net Cash
$21.00M
-94.3%
Accounts Receivable
$33.85M
-17.0%
Inventory
$0.00
N/A
Long Term Debt
$288.56M
+1944.8%
Short Term Debt
$2.08M
+8.1%
Return on Assets
-3.63%
N/A
Return on Invested Capital
14.70%
N/A
Free Cash Flow
$98.00M
+246.4%
Operating Cash Flow
$98.00M
+247.0%